Epitol
- Product NDC
- 0093-0090
- 11-digit product format
- 000930090
- Labeler code
- 0093
- Product ID
- 0093-0090_5c31da75-fc21-4ab2-9487-64169767ebd0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Carbamazepine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Application
- ANDA070541
- Marketing category
- ANDA
- Marketing start
- 1990-09-30
- Marketing end
- 2026-07-31
- Substance
- CARBAMAZEPINE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]
- NDC exclude flag
- No
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Epitol
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CARBAMAZEPINE | 200 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 33CM23913M |
| Rxcui | 211817, 308979 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0093-0090-01 | Epitol | 100 in 1 BOTTLE | TABLET | 100 | | 18 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0093-0090 | EPITOL (CARBAMAZEPINE) TABLET [TEVA PHARMACEUTICALS USA, INC.] | 17 | Current NDC, Legacy NDC, 1 package rows | 20240331_32bbe864-7374-44da-8c6e-e733f0648243.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0093-0090-01 | 00093009001 | 100 TABLET in 1 BOTTLE (0093-0090-01) | 100 tablet | 1990-09-30 | 2026-07-31 | No | No | Current |